Holistic FeNO monitoring for better asthma therapy
Worldwide unique combination: FeNO measurement in medical practice and at home
The biomarker FeNO can significantly improve the diagnosis and therapy of asthma. The Vivatmo devices from Bosch measure FeNO in exhaled breath simply and precisely. Vivatmo is the world's first and only FeNO monitoring system that combines measurement in the medical practice with measurement at home. This opens up completely new dimensions in asthma management – such as more precise medication or better control of adherence and exacerbations in dialogue with the patient.
Bosch Healthcare Solutions
Innovative diagnostics for a better quality of life
Bosch Healthcare Solutions (BHCS) is a wholly-owned subsidiary of Robert Bosch GmbH and was founded in 2015. We create innovative diagnostic solutions to improve people's quality of life and global healthcare.
This website contains general product information about the Vivatmo system from Bosch. Not all products and their functions mentioned here are approved in every regional market. For a detailed description of the products and features as well as information on intended and safe use, please refer to your locally authorized Bosch distribution partner and the instructions for use that are valid for your country.